transplant
Oral Antibiotic Therapy for Uncomplicated BSIs: Safe Alternative to IV Therapy in Transplants
Oral antibiotic step-down therapy for uncomplicated gram-negative bloodstream infections in solid-organ transplant ...
FEBRUARY 24, 2025
Prevymis Gets Priority Review for New Indication Decision
Merck is seeking two new indications for Prevymis against cytomegalovirus in transplant patients.
FEBRUARY 17, 2023
FDA Expands Indication for CellCept to Pediatric Heart Transplant and Liver Transplant
Mycophenolate mofetil should be prescribed in combination with other immunosuppressants. The medication is ...
JUNE 10, 2022
FDA Grants New Indication for Orencia for Acute Graft-Versus-Host Disease Prophylaxis
Acute GvHD affects up to 70% of patients who receive an HSCT, particularly those coming from unrelated and ...
DECEMBER 17, 2021
FDA Approves Livtencity for Resistant Post-Transplant CMV
Although a rare disease overall, CMV is one of the most common infections experienced by both HSCT and SOT ...
NOVEMBER 24, 2021
Woman Contracts COVID-19 From Lung Transplant
A woman contracted COVID-19 and died after receiving a double lung transplant from a donor who harbored the ...
MAY 28, 2021
M. hominis Infection May Be Passed From Transplant Donor to Recipient
M. hominis presents a challenge for clinicians, as the bacterium is difficult to identify and resistant to many ...
MAY 23, 2017
HCV Drugs May Slash Wait Times for Transplants
For a quarter of a century, organs from donors with HCV have been considered unusable for transplant. But now that ...
MARCH 8, 2017
